Skip to content

CDSS-assisted UGI Endoscopy vs. Routine Screening Endoscopy

Clinical Benefit in the CDSS-assisted Screening Upper Gastrointestinal Endoscopy vs. Routine Screening Endoscopy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05452473
Enrollment
1200
Registered
2022-07-11
Start date
2022-07-06
Completion date
2022-12-06
Last updated
2022-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Individual

Keywords

Convolutional neural network, Deep learning, Endoscopy, Gastric neoplasms

Brief summary

This study aimed to find the CDSS-assisted upper GI endoscopy has clinical benefit compared to conventional routine screening upper GI endoscopy. Investigators will conduct a pilot randomized controlled study. Consecutive patients will be allocated either to CDSS-assisted upper GI endoscopy or conventional routine screening upper GI endoscopy. The lesion detection rate will be compared between both groups.

Detailed description

Artificial intelligence has been adopted in the field of gastrointestinal endoscopy. Investigators previously established deep-learning models to predict the histology and invasion depth of gastric lesions using endoscopic stillcut images. However, clinical benefit of this model has not been evaluated. This study aimed to find the CDSS-assisted upper GI endoscopy has clinical benefit compared to conventional routine screening upper GI endoscopy. Investigators will conduct a pilot randomized controlled study. Consecutive patients who visited Chuncheon Sacred Heart hospital will be allocated either to CDSS-assisted upper GI endoscopy or conventional routine screening upper GI endoscopy. The lesion detection rate will be compared between both groups. Expert endoscopists will conduct this randomized study.

Interventions

OTHERCDSS-assisted upper GI endoscopy

Expert endoscopists perform screening upper gastrointestinal endoscopy while looking at the monitor (CDSS system: automatic detection or lesion classification function) and listening to the sound of the monitor next to the original endoscopy monitor system.

OTHERno intervention

Expert endoscopists perform routine screening upper gastrointestinal endoscopy without CDSS's help.

Sponsors

Chuncheon Sacred Heart Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participants who visited for routine screening upper gastrointestinal endoscopy

Exclusion criteria

* Participants who refuse to participate in this study * Participants who showed paradoxical reaction prohibiting routine examination

Design outcomes

Primary

MeasureTime frameDescription
Gastric lesion detection rateBaseline (gold standard; ground truth is expert endoscopists' lesion detection)Gastric lesions (low or high grade dysplasia, early gastric cancer, or advanced gastric cancer) detection rate

Secondary

MeasureTime frameDescription
Lesion classification accuracyBaseline (gold standard; ground truth is histologic diagnosis of detected lesions)Whether CDSS correctly diagnosed detected lesions or not

Countries

South Korea

Contacts

Primary ContactChang Seok Bang, MD., PhD.
csbang@hallym.ac.kr+82332405000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026